Abstract:Background: Nuclear factor kappa B (NF-kappa B)-mediated pathways have been widely implicated in cell survival, development and tumor progression. Although the molecular events of determining NF-kappa B translocation from cytoplasm to nucleus have been extensively documented, the regulatory mechanisms of NF-kappa B activity inside the nucleus are still poorly understood. Being a special member of macro domain proteins, LRP16 was previously identified as a coactivator of both estrogen receptor and androgen receptor, and as an interactor of NF-kappa B coactivator UXT. Here, we investigated the regulatory role of LRP16 on NF-kappa B activation.Methodology: GST pull-down and coimmunoprecipitation (CoIP) assays assessed protein-protein interactions. The functional activity of NF-kappa B was assessed by luciferase assays, changes in expression of its target genes, and its DNA binding ability. Annexin V staining and flow cytometry analysis were used to evaluate cell apoptosis. Immunohistochemical staining of LRP16 and enzyme-linked immunosorbent assay-based evaluation of active NF-kappa B were performed on primary human gastric carcinoma samples.Results: We demonstrate that LRP16 integrates into NF-kappa B transcriptional complex through associating with its p65 component. RNA interference knockdown of the endogenous LRP16 in cells leads to impaired NF-kappa B activity and significantly attenuated NF-kappa B-dependent gene expression. Mechanistic analysis revealed that knockdown of LRP16 did not affect tumor necrosis factor a (TNF-alpha)-induced nuclear translocation of NF-kappa B, but blunted the formation or stabilization of functional NF-kappa B/p300/CREB-binding protein transcription complex in the nucleus. In addition, knockdown of LRP16 also sensitizes cells to apoptosis induced by TNF-alpha. Finally, a positive link between LRP16 expression intensity in nuclei of tumor cells and NF-kappa B activity was preliminarily established in human gastric carcinoma specimens.Conclusions: Our findings not only indicate that LRP16 is a crucial regulator for NF-kappa B activation inside the nucleus, but also suggest that LRP16 may be an important contributor to the aberrant activation of NF-kappa B in tumors.

Lrrc25 Functions As An Inhibitor Of Nf-Kappa B Signaling Pathway By Promoting P65/Rela For Autophagic Degradation

LRRC25 Functions as an Inhibitor of NF-κB Signaling Pathway by Promoting p65/RelA for Autophagic Degradation

LRRC14 Attenuates Toll-like Receptor-Mediated NF-κB Signaling Through Disruption of IKK Complex.

Identification and characterization of a unique leucine-rich repeat protein (LRRC33) that inhibits Toll-like receptor-mediated NF-κB activation.

NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways

Epigenetically modulated LRRC33 acts as a negative physiological regulator for multiple Toll-like receptors.

Reversible Ubiquitination Shapes NLRC5 Function and Modulates NF-κB Activation Switch

Genome-wide Mapping of RELA(p65) Binding Identifies E2F1 as a Transcriptional Activator Recruited by NF-κB upon TLR4 Activation

LRRC19 Recognize Poinflammatory Cytokine Tumor Necrosis Factor α and Participate Immune Response in Kidney

NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways

The regulation of NLRP3 inflammasome activation by CCDC50-mediated autophagy

CCDC50 Suppresses NLRP3 Inflammasome Activity by Mediating Autophagic Degradation of NLRP3

LRRC25 Inhibits IFN-γ Secretion by Microglia to Negatively Regulate Anti-Tuberculosis Immunity in Mice

The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy

Lrp16 Integrates Into Nf-Kappa B Transcriptional Complex And Is Required For Its Functional Activation

NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK

Role of the NF-κB Family Member RelB in Regulation of Foxp3+ Regulatory T Cells in Vivo.

LRRC59 modulates type I interferon signaling by restraining the SQSTM1/p62-mediated autophagic degradation of pattern recognition receptor DDX58/RIG-I

NLRC5: A Paradigm for NLRs in Immunological and Inflammatory Reaction.

E3 Ubiquitin Ligase RNF13 Suppresses TLR Lysosomal Degradation by Promoting LAMP‐1 Proteasomal Degradation

Lipopolysaccharide promotes NLRP3 inflammasome activation by inhibiting TFEB-mediated autophagy in NRK-52E cells